Archive for November 30th, 2011

TSPT marketing deal. MRNA reverse split likely soon + NBY news

Nov 30, 2011 No Comments by

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today that Purdue has exercised its option to commercialize Intermezzo in the United States. Purdue plans to launch Intermezzo in 2Q 2012 and to invest approximately $100 million to support sales and marketing during the first year of commercialization. Purdue has the right to negotiate for the commercialization of […]

Daily News Read more

HZNP PDUFA date announced. OMER CYTK ALNY trial updates + INFI

Nov 30, 2011 No Comments by

Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that the FDA has accepted for filing and review its New Drug Application (NDA) for LODOTRA, a proprietary modified (delayed)-release formulation of low-dose prednisone, for the treatment of rheumatoid arthritis (RA) in adults, and set a PDUFA date of July 26, 2012, based on the standard 10 month […]

Daily News Read more